Neuromuscular diseases: evaluation with high-frequency sonography.

Area of Science:

• Neurology
• Medical Imaging
• Biomedical Engineering

Background:

• Neuromuscular diseases present diagnostic challenges.
• Accurate differentiation is crucial for effective treatment and management.
• Noninvasive diagnostic tools are highly desirable.

Purpose of the Study:

• To evaluate the utility of high-frequency ultrasound in differentiating neuromuscular diseases.
• To determine if the number of perimysial septa can serve as a diagnostic biomarker.
• To correlate ultrasound findings with muscle biopsy results.

Main Methods:

• High-frequency ultrasound was performed on rectus femoris, vastus medialis, vastus lateralis, and biceps brachii muscles.
• The number of perimysial septa and muscle/soft-tissue ratios were quantified.
• Findings were compared between 44 patients with suspected neuromuscular disease and 12 healthy volunteers.
• Results were correlated with muscle biopsy data.

Main Results:

• Significant differences in perimysial septa counts were observed between healthy volunteers and patients with Duchenne muscular dystrophies, other muscular dystrophies, and spinal muscular atrophies.
• A receiver operating characteristic curve analysis identified an average of 12 perimysial septa within 1 cm of muscle as an ideal cutoff value.
• This cutoff effectively differentiated subjects without morphologic changes from those with pathological findings.

Conclusions:

• The number of perimysial septa measured by high-frequency ultrasound is a useful, noninvasive, and reproducible method for differentiating neuromuscular diseases.
• This technique holds potential for monitoring disease progression.